Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Choi

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Cancers|December 26, 2018
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical TrialsNatalie Galanina, Rafael Bejar, Michael Choi, et al.
Blood Advances|June 14, 2023
Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE studyCarol Moreno, Isabelle G Solman, Constantine S Tam, et al.
British Journal of Haematology|November 28, 2018
Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitorWilliam G Wierda, John C Byrd, Matthew S Davids, et al.
Cancer|May 26, 2018
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinibMax J Gordon, Michael Churnetski, Hamood Alqahtani, et al.
Leukemia Research|January 27, 2020
A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort studyMax J Gordon, Andrea Sitlinger, Tareq Salous, et al.
Blood|January 7, 2018
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapySteven Coutre, Michael Choi, Richard R Furman, et al.
Theranostics|January 4, 2021
A role for intestinal alkaline phosphatase in preventing liver fibrosisYang Liu, Paul M Cavallaro, Byeong-Moo Kim, et al.
Journal for Immunotherapy of Cancer|February 5, 2024
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cellsGregory P Botta, Joseph Chao, Hong Ma, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 24, 2012
Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trialL Ebony Boulware, Felicia Hill-Briggs, Edward S Kraus, et al.
Haematologica|March 30, 2019
Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapyAnthony R Mato, William G Wierda, Matthew S Davids, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Cancers|December 26, 2018
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical TrialsNatalie Galanina, Rafael Bejar, Michael Choi, et al.
Blood Advances|June 14, 2023
Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE studyCarol Moreno, Isabelle G Solman, Constantine S Tam, et al.
British Journal of Haematology|November 28, 2018
Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitorWilliam G Wierda, John C Byrd, Matthew S Davids, et al.
Cancer|May 26, 2018
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinibMax J Gordon, Michael Churnetski, Hamood Alqahtani, et al.
Leukemia Research|January 27, 2020
A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort studyMax J Gordon, Andrea Sitlinger, Tareq Salous, et al.
Blood|January 7, 2018
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapySteven Coutre, Michael Choi, Richard R Furman, et al.
Theranostics|January 4, 2021
A role for intestinal alkaline phosphatase in preventing liver fibrosisYang Liu, Paul M Cavallaro, Byeong-Moo Kim, et al.
Journal for Immunotherapy of Cancer|February 5, 2024
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cellsGregory P Botta, Joseph Chao, Hong Ma, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 24, 2012
Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trialL Ebony Boulware, Felicia Hill-Briggs, Edward S Kraus, et al.
Haematologica|March 30, 2019
Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapyAnthony R Mato, William G Wierda, Matthew S Davids, et al.
Pageof 8